- For Some, ‘Tis the Season for Loneliness. Experts Offer Tips to Stay Connected
- Taking a GLP-1 Medication? Here’s Tips to Holiday Eating
- Bird Flu Virus in Canadian Teen Shows Mutations That Could Help It Spread Among Humans
- Flu, COVID Vaccination Rates Remain Low as Winter Nears
- ’10 Americas:’ Health Disparities Mean Life Expectancy Varies Across U.S.
- Short-Term Hormone Therapy for Menopause Won’t Harm Women’s Brains
- Could a Vitamin Be Effective Treatment for COPD?
- Woman Receives World’s First Robotic Double-Lung Transplant
- Flavored Vapes Behind Big Surge in U.S. E-Cigarette Sales
- Reading Beyond Headline Rare For Most on Social Media, Study Finds
Health Highlights: April 10, 2019
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
Dozens Charged in Medicare Brace Scam
Two dozen people have been charged in an orthopedic brace scam that cost Medicare more than $1.2 billion.
The scheme sold unneeded back, shoulder, wrist and knee braces to hundreds of thousands of seniors, using overseas calls centers to get Medicare numbers from beneficiaries, the Associated Press reported.
Those charged include doctors accused of writing fake prescriptions, telemedicine firms, medical equipment companies and owners of call centers.
Action is being taken against the 130 medical equipment companies implicated in the scam, according to Medicare’s anti-fraud unit, the AP reported.
—–
Senate Committee Grills Pharmacy Benefit Managers on High Drug Prices
Pharmacy benefit managers came under heavy fire Tuesday at a Senate Finance Committee hearing on high drug prices.
Pharmacy benefit managers handle prescription drug coverage for their clients. They create lists of covered drugs and negotiate rebates for some drugs to help offset high list prices, according to the Associated Press.
Some view these managers as middlemen who add costs to an already expensive system for prescription drugs. Pharmaceutical companies say that rebates are part of the problem.
During the hearing, lawmakers asked the managers why they can’t do more to control prices and to provide details on the contracts they negotiate, the wire service reported.
Executives from CVS Health, UnitedHealth Group’s OptumRx and Cigna testified at the hearing. The three companies represent 76 percent of the market, according to the AP.
This was the committee’s third hearing this year on the high cost of prescription drugs, the AP reported.
——
U.S. Measles Cases This Year Reach 465: CDC
The number of reported measles cases in the United States hit 465 as of April 4, the U.S. Centers for Disease Control and Prevention said Monday.
That’s 78 more than in the previous week’s update, CNN reported.
The update said that Florida, Indiana, Massachusetts and Nevada had their first cases of measles this year, bringing the total number of states reporting cases to 19.
The other states are Arizona, California, Colorado, Connecticut, Georgia, Illinois, Kentucky, Michigan, Missouri, New Hampshire, New Jersey, New York, Oregon, Texas and Washington, CNN reported.
The number of measles cases this year “is the second greatest number of cases reported in the U.S. since measles was eliminated in 2000,” according to the CDC.
Last year’s total was 372 cases. The largest outbreak occurred in 2014, with 667 cases, CNN reported.
Measles is highly contagious, but it can be prevented through vaccination. One reason for the rising number of measles cases is anti-vaccine misinformation being spread by so-called anti-vaxxers, experts say.
Copyright © 2024 HealthDay. All rights reserved.